Offer - Urjas Oil for just ₹ 1 X
Lamistar 40 Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Lamistar 40 Tablet have also been mentioned below.
The right dosage of Lamistar 40 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Lamistar 40 Tablet can also lead to other problems, which have been listed below. These side effects of Lamistar 40 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Lamistar 40 Tablet has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Lamistar 40 Tablet's effects on the liver, heart and kidney are discussed below in the Lamistar 40 Tablet related warnings section.
Lamistar 40 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Pancreatitis, Liver Disease are examples of such conditions. Some other conditions that can be affected by Lamistar 40 Tablet are listed in the contraindications section below.
Drug reaction of Lamistar 40 Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Lamistar 40 Tablet is considered not safe while driving, and is not addictive.
Lamistar 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Lamistar 40 Tablet safe for pregnant women?
Lamistar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Lamistar right away. Take your doctor's advice before taking it again.
Is the use of Lamistar 40 Tablet safe during breastfeeding?
Side effects of Lamistar on breastfeeding women are very mild.
What is the effect of Lamistar 40 Tablet on the Kidneys?
Lamistar has very mild side effects on the kidneys.
What is the effect of Lamistar 40 Tablet on the Liver?
Very few cases of side effects of Lamistar on the liver have been reported.
What is the effect of Lamistar 40 Tablet on the Heart?
Lamistar is completely safe for the heart.
Lamistar 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lamistar 40 Tablet unless your doctor advises you to do so -
Is this Lamistar 40 Tablet habit forming or addictive?
Forming a habit of Lamistar 40 Tablet has not been reported.
Interaction between Food and Lamistar 40 Tablet
Taking Lamistar 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Lamistar 40 Tablet
Consumption of alcohol and Lamistar 40 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807